Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (201-210 of 205) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 205 results.
American Heart Journal|April 15, 2018
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patientsPatrice Cacoub, Pierre Nahon, Richard Layese, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 13, 2022
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohortsIsabelle Ollivier-Hourmand, Yohann Repesse, Pierre Nahon, et al.
Journal of Hepatology|November 23, 2020
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Journal of Hepatology|July 17, 2020
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiologyJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Journal of Hepatology|February 23, 2026
Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohortsCornelius Engelmann, Nipun Verma, Tingting Qi, et al.
Pageof 21

Showing results (201-210 of 205) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 205 results.
American Heart Journal|April 15, 2018
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patientsPatrice Cacoub, Pierre Nahon, Richard Layese, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 13, 2022
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohortsIsabelle Ollivier-Hourmand, Yohann Repesse, Pierre Nahon, et al.
Journal of Hepatology|November 23, 2020
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Journal of Hepatology|July 17, 2020
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiologyJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Journal of Hepatology|February 23, 2026
Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohortsCornelius Engelmann, Nipun Verma, Tingting Qi, et al.
Pageof 21